Gilead Sciences (GILD) News Today $89.84 +1.21 (+1.37%) (As of 11/21/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Thompson Siegel & Walmsley LLC Buys 43,921 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Thompson Siegel & Walmsley LLC raised its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 65.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 111,305 shares of the biopharmaceutical cNovember 22 at 6:34 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by BNP PARIBAS ASSET MANAGEMENT Holding S.A.BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 38.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 764,520 shares of the biopharNovember 22 at 5:44 AM | marketbeat.comCommerce Bank Purchases 7,055 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Commerce Bank grew its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 10.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 72,494 shares of the biopharmaceutical company's stockNovember 22 at 4:51 AM | marketbeat.comDaiwa America Upgrades Gilead Sciences (NASDAQ:GILD) to "Hold"November 22 at 1:48 AM | americanbankingnews.comGilead price target raised to $100 from $90 at MizuhoNovember 21 at 5:14 PM | markets.businessinsider.comGilead Sciences (NASDAQ:GILD) Price Target Raised to $100.00Mizuho raised their price target on shares of Gilead Sciences from $90.00 to $100.00 and gave the company an "outperform" rating in a research report on Thursday.November 21 at 8:31 AM | marketbeat.comGilead Sciences Q3 Earnings TranscriptNovember 21 at 7:09 AM | marketbeat.comIntech Investment Management LLC Decreases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Intech Investment Management LLC lessened its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 29.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 192,549 shares of the biopharmaceutical company's stocNovember 21 at 7:02 AM | marketbeat.comGilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by Daiwa AmericaDaiwa America raised shares of Gilead Sciences to a "hold" rating in a report on Monday.November 21 at 6:32 AM | marketbeat.comHow Gilead Is Driving Global Health Equity And InnovationNovember 21 at 6:26 AM | forbes.comPNC Financial Services Group Inc. Increases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)PNC Financial Services Group Inc. lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 7.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 390,175 shares of the biopharmaceutNovember 21 at 4:53 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Position Increased by Natixis Advisors LLCNatixis Advisors LLC grew its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 18.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 169,363 shares of the biopharmaceutical company's stock aNovember 21 at 3:51 AM | marketbeat.comGilead Sciences (GILD) Announces Issuance of Senior Notes in New Indenture AgreementNovember 21 at 2:06 AM | gurufocus.comGilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lowered by Ontario Teachers Pension Plan BoardOntario Teachers Pension Plan Board lowered its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 63.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 23,965 shares of the biopharmaceutical company's stock after selling 42,207 shareNovember 20 at 8:41 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by First Horizon Advisors Inc.First Horizon Advisors Inc. boosted its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 8.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 274,687 shares of the biopharmaceutical company's stock after purchasing an additional 20,312 shares duringNovember 20 at 8:30 AM | marketbeat.comAdvisors Asset Management Inc. Sells 18,896 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Advisors Asset Management Inc. lowered its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 254,836 shares of the biopharmaceutical company's stock after selling 18,896 shares during the peNovember 20 at 8:18 AM | marketbeat.comB. Metzler seel. Sohn & Co. Holding AG Takes $9.52 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 113,501 shares of the biopharmNovember 20 at 5:56 AM | marketbeat.comProspera Financial Services Inc Has $6.59 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Prospera Financial Services Inc grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 26.9% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 78,615 shares of the biopharmaceuticalNovember 20 at 5:30 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twenty-five analysts that are currently covering the company, Marketbeat.com reports. Eleven equities research analysts have rated the stock with a hold recommendation, elNovember 20 at 3:32 AM | marketbeat.comGilead Sciences (NASDAQ:GILD) Price Target Raised to $84.00 at Royal Bank of CanadaNovember 20 at 2:58 AM | americanbankingnews.comParnassus Investments LLC Sells 280,937 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Parnassus Investments LLC decreased its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 19.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,151,874 shares of the biopharmaceutical comNovember 19 at 9:14 AM | marketbeat.comMeeder Asset Management Inc. Purchases 42,444 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Meeder Asset Management Inc. raised its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 28.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 190,035 shares of the biopharmaceutical company's sNovember 19 at 7:12 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Belmont Capital LLCBelmont Capital LLC trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 46.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 12,412 shares of the biopharmaceutical company's stoNovember 19 at 6:51 AM | marketbeat.comGilead price target raised to $84 from $81 at RBC CapitalNovember 18, 2024 | markets.businessinsider.comRoyal Bank of Canada Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) StockRoyal Bank of Canada boosted their price target on shares of Gilead Sciences from $81.00 to $84.00 and gave the company a "sector perform" rating in a research report on Monday.November 18, 2024 | marketbeat.com5,715 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Aljian Capital Management LLCAljian Capital Management LLC purchased a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 5,715 shares of the biopharmaceutical company's stock,November 18, 2024 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by TrinityPoint Wealth LLCTrinityPoint Wealth LLC grew its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 658.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 43,606 shares of the biopharmaceutical company'November 18, 2024 | marketbeat.comSwiss National Bank Purchases 5,900 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Swiss National Bank raised its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 0.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,697,900 shares of the biopharmaceutical company's stock afteNovember 17, 2024 | marketbeat.comThrivent Financial for Lutherans Acquires 28,090 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Thrivent Financial for Lutherans increased its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 1.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,187,446 shares of the biopharmaceuticalNovember 17, 2024 | marketbeat.com14,342 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Atlanta Consulting Group Advisors LLCAtlanta Consulting Group Advisors LLC purchased a new position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 14,342 shares of the biopharmaceutical company's stock, valued at approximately $1,202November 17, 2024 | marketbeat.comGilead announces data from interim analysis of Phase 3 ASSURE studyNovember 17, 2024 | markets.businessinsider.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Kentucky Retirement SystemsKentucky Retirement Systems trimmed its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 7.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 86,733 shares of the biopharmaceutical compaNovember 16, 2024 | marketbeat.comCitigroup Initiates Coverage of Gilead Sciences (GILD) with Buy RecommendationNovember 16, 2024 | msn.comWolfe Research Initiates Coverage of Gilead Sciences (GILD) with Outperform RecommendationNovember 16, 2024 | msn.comCIBC Asset Management Inc Purchases 22,624 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)CIBC Asset Management Inc lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 5.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 439,370 shares of the biopharmaceutical cNovember 16, 2024 | marketbeat.comImpax Asset Management Group plc Sells 7,979 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Impax Asset Management Group plc reduced its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 4.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 167,742 shares of the biopharNovember 16, 2024 | marketbeat.comGilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver DiseaseNovember 15, 2024 | benzinga.comSimplify Asset Management Inc. Buys New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Simplify Asset Management Inc. acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 96,202 shares of the biopharmaceutical company'sNovember 15, 2024 | marketbeat.comGilead's Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary CholangitisNovember 15, 2024 | businesswire.comEmpowered Funds LLC Reduces Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Empowered Funds LLC reduced its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 42.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 140,922 shares of the biopharmaceutical company's stock after selling 103,596 shares during the perNovember 15, 2024 | marketbeat.comCornercap Investment Counsel Inc. Has $1.85 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Cornercap Investment Counsel Inc. reduced its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 33.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,086 shares of the biopharmaceuticaNovember 15, 2024 | marketbeat.comGilead Sciences (NASDAQ:GILD) Coverage Initiated at Wolfe ResearchWolfe Research began coverage on Gilead Sciences in a report on Friday. They set an "outperform" rating and a $110.00 price target on the stock.November 15, 2024 | marketbeat.comDearborn Partners LLC Has $26.76 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Dearborn Partners LLC cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 3.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 319,125 shares of the biopharmaceutical company's stock after sellingNovember 15, 2024 | marketbeat.comIntellectus Partners LLC Lowers Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Intellectus Partners LLC cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 47.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,429 shares of the biopharmaceutical comNovember 15, 2024 | marketbeat.comCitigroup Upgrades Gilead Sciences (NASDAQ:GILD) to Strong-BuyCitigroup upgraded Gilead Sciences to a "strong-buy" rating in a research report on Wednesday.November 15, 2024 | marketbeat.comGilead Sciences' (NASDAQ:GILD) Soft Earnings Are Actually Better Than They AppearNovember 15, 2024 | sg.finance.yahoo.comGilead Sciences (GILD) Gets a Buy from TD CowenNovember 14, 2024 | markets.businessinsider.comING Groep NV Buys 109,788 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)ING Groep NV grew its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 38.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 392,685 shares of the biopharmaceutical companyNovember 14, 2024 | marketbeat.comZions Bancorporation N.A. Boosts Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Zions Bancorporation N.A. increased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.8% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 115,611 shares of the biopharmaceutical company's stock after purchasing an additional 7,33November 14, 2024 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by KBC Group NVKBC Group NV reduced its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 37.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,282,519 shares of the biopharmaceuticNovember 14, 2024 | marketbeat.com Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Democrats Sold Out the American Dream - Are you ready? (Ad)There's a massive housing crisis looming, and nobody on Main Street knows it yet... The Democrats sold out the American Dream - and now, millions of Americans are locked out of the housing market, forced to become "permanent renters." Click here to see exactly what you need to do >>> GILD Media Mentions By Week GILD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼1.090.48▲Average Medical News Sentiment GILD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼4819▲GILD Articles Average Week Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMGN News Today VRTX News Today REGN News Today ALNY News Today BIIB News Today UTHR News Today MRNA News Today INCY News Today NBIX News Today BMRN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GILD Stock Alerts